GOODRX HOLDINGS INC-CLASS A (GDRX) Stock News
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
GDRX Latest News, Press Relases and Analysis
GoodRx to Launch Direct Contracting for Independent Community Pharmacies
Morgan Stanley Raises The Progressive Corporation (PGR)’s Price Target to $330 from $320, Maintains Overweight Rating
On May 19, Morgan Stanley analyst Bob Huang raised The Progressive Corporation (NYSE:PGR)’s price target to $330 per share, representing a 3.12% increase from the prior target price of $320. The raise reflects the analysts’ strong confidence in the company’s future performance. The stock has surged 20% year-to-date, comfortably outpacing the broader market index, which […]
UBS Upgrades Archer Daniels (ADM) Stock to Buy, Lifts PT
On May 19, UBS analyst Manav Gupta upped Archer-Daniels-Midland Company (NYSE:ADM)’s stock from “Neutral” to “Buy,” raising the price objective to $60 from the prior target of $55. The analyst highlighted the potential policy benefits, together with an optimistic outlook for its nutrition segment, as critical drivers. The House’s budget reconciliation bill has made it […]
GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?
GDRX vs. PGNY: Which Stock Is the Better Value Option?
Mentions: PGNY
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
JP Morgan analyst Lisa C. Gill revised her 2025 outlook on GoodRx Holdings (NASDAQ:GDRX) following the company’s first-quarter earnings. Gill reaffirmed an Overweight rating on the stock and maintained her $7 price forecast. The company reported first-quarter 2025 revenue of $203 million (above the $202.21 million estimate), up 3% year-over-year. Adjusted EBITDA rose to $69.8 million, with margins improving to 34.4% from 31.7%. Net income came in at $11.1 million, reversing a $1 million loss in
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.
Mentions: JPM
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx are included in this Analyst Blog.
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns
Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX.
Nissan abandons plan for $1.1 billion EV battery plant in southern Japan
TOKYO (Reuters) -Nissan Motor said on Friday it would abandon a plan to build a $1.1 billion factory for electric vehicle batteries on Japan's southwestern island of Kyushu, marking the latest change of plans for the troubled automaker. The company is also preparing to offer early retirement to several hundred staff in Japan, the Nikkei newspaper reported later on Friday, a move that would mark the first such headcount reduction at home in 18 years. Nissan declined to comment on the Nikkei report.
Apple Inc. (AAPL) – AI Innovation Key to Sustained Market Leadership
We recently published a list of 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other AI stocks on Wall Street’s radar right now. According to a state media report, China’s President Xi Jinping has pledged “self-reliance and […]
Meta Platforms, Inc. (META): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential
We recently published a list of Billionaire David Abrams’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Meta Platforms, Inc. (NASDAQ:META) stands against other stock picks with huge upside potential. David Abrams founded Abrams Capital Management in 1999. Before forming the Boston-based investment firm, Abrams worked […]
Why ConocoPhillips Stock Zoomed Higher on Thursday
It topped the average analyst estimates for both revenue and profitability. ConocoPhillips (NYSE: COP) stock closed Wednesday in positive territory. On the back of a solid quarterly earnings beat, investors pushed it to a 1.4% gain, good enough to top the 0.6% bump of the S&P 500 (SNPINDEX: ^GSPC).
Why GoodRx Holdings Stock Triumphed on Thursday
The healthcare services specialist unveiled its first set of quarterly results for this year. It beat on both the top and bottom lines, and slightly increased its guidance for a profitability metric. Niche healthcare company GoodRx Holdings (NASDAQ: GDRX) was looking spry and healthy on the stock market Thursday.
Is GoodRx (GDRX) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Beyond Meat Shelves Full-Year Outlook After $7M Hit — CEO Warns Of 'Unforeseen' Economic Headwinds, But Downplays Tariff Threat
Beyond Meat Inc. (NASDAQ:BYND) missed analyst expectations in the first quarter of the ongoing fiscal year and withdrew its full-year revenue guidance, citing the ongoing economic uncertainties. However, the CEO forecasted a “relatively minimal” tariff impact on the firm. What Happened: The plant-based meat company withdrew its full-year guidance and limited its revised outlook to the second quarter net revenue expectations only. “As with many other companies, we are experiencing an elevated lev
Compared to Estimates, GoodRx (GDRX) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for GoodRx (GDRX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
GoodRx (GDRX) delivered earnings and revenue surprises of 0% and 0.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: HQY
GoodRx’s (NASDAQ:GDRX) Q1 Earnings Results: Revenue In Line With Expectations, Stock Jumps 10.3%
Healthcare tech company GoodRx (NASDAQ:GDRX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $203 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $825 million at the midpoint. Its non-GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
GoodRx Reports First Quarter 2025 Results
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect
Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting results tomorrow after the bell. Here’s what you need to know.
GoodRx Holdings, Inc. (GDRX) Reports Next Week: Wall Street Expects Earnings Growth
GoodRx (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Bumble Inc. (BMBL) the Most Undervalued Penny Stock to Buy According to Hedge Funds?
We recently published a list of the 10 Most Undervalued Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Bumble Inc. (NASDAQ:BMBL) stands against other undervalued penny stocks. Earlier on March 18, Keith Fitz-Gerald, Fitz-Gerald Group CIO, joined ‘Power Lunch’ on CNBC to talk […]
Jim Cramer Says You Should Buy Louisiana-Pacific (LPX) Amid Trump Tariffs on Canada
We recently published a list of 10 Jim Cramer Stocks to Buy and Sell Now. In this article, we are going to take a look at where Louisiana-Pacific Corporation (NYSE:LPX) stands against other stocks that Jim Cramer discussed. Jim Cramer in a latest program on CNBC talked about President Donald Trump’s attack on Federal Reserve […]
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call
Here’s How Long You Should Hold Onto Tax Filing Paperwork, According to an Expert
Do you ever wonder how long you should hang onto your tax paperwork? This form of recordkeeping may lead taxpayers to ask how long they need to keep and store documentation or if they are meant to...
Is Coca-Cola Company (KO) the Best Stock to Buy According to Billionaire Steve Cohen?
We recently published a list of 10 Best Stocks to Buy According to Billionaire Steve Cohen. In this article, we are going to take a look at where The Coca-Cola Company (NYSE:KO) stands against other best stocks to buy according to billionaire Steve Cohen. Steve Cohen, a prominent figure in the world of hedge funds, […]
GoodRx Introduces New E-commerce Experience for Retail Pharmacies
